4544 Stock Overview
Operates healthcare business in Japan, the United States, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
H.U. Group Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,513.00 |
| 52 Week High | JP¥2,863.00 |
| 52 Week Low | JP¥2,167.00 |
| Beta | 0.46 |
| 1 Month Change | 11.10% |
| 3 Month Change | -4.01% |
| 1 Year Change | -9.39% |
| 3 Year Change | -13.40% |
| 5 Year Change | -7.58% |
| Change since IPO | 139.33% |
Recent News & Updates
Shareholder Returns
| 4544 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 1.5% | 3.9% | 0.4% |
| 1Y | -9.4% | 1.5% | 21.7% |
Return vs Industry: 4544 underperformed the JP Healthcare industry which returned 1.5% over the past year.
Return vs Market: 4544 underperformed the JP Market which returned 21.7% over the past year.
Price Volatility
| 4544 volatility | |
|---|---|
| 4544 Average Weekly Movement | 4.8% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4544 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4544's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | 5,437 | Shigekazu Takeuchi | www.hugp.com |
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment collects specimens from medical offices, clinics, and hospitals, and conducts various tests at its laboratories. The segment also provides precision of the tests, pre-trial setup work, specimen collection and transport, measuring, result reports, and data management services for support in research and development of medicine.
H.U. Group Holdings, Inc. Fundamentals Summary
| 4544 fundamental statistics | |
|---|---|
| Market cap | JP¥142.79b |
| Earnings (TTM) | -JP¥7.55b |
| Revenue (TTM) | JP¥236.95b |
0.6x
P/S Ratio-18.9x
P/E RatioIs 4544 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4544 income statement (TTM) | |
|---|---|
| Revenue | JP¥236.95b |
| Cost of Revenue | JP¥173.72b |
| Gross Profit | JP¥63.24b |
| Other Expenses | JP¥70.79b |
| Earnings | -JP¥7.55b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -132.93 |
| Gross Margin | 26.69% |
| Net Profit Margin | -3.19% |
| Debt/Equity Ratio | 49.2% |
How did 4544 perform over the long term?
See historical performance and comparison